全球植物抗體市場

預計到 2030 年全球植物抗體市場規模將達到 7,950 萬美元

全球植物抗體市場規模預計在2024年為5,320萬美元，到2030年將達到7,950萬美元，2024年至2030年的複合年成長率為6.9%。菸草是本報告分析的細分市場之一，預計其複合年成長率為8.8%，到分析期結束時規模將達到2,430萬美元。豆類細分市場在分析期間內的複合年成長率預計為4.6%。

美國市場規模估計為 1,450 萬美元，而中國市場預計複合年成長率為 11.2%

預計到2024年，美國植物抗體市場規模將達到1,450萬美元。作為世界第二大經濟體，中國市場規模預計將在2030年達到1,690萬美元，2024年至2030年的複合年成長率為11.2%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間的複合年成長率分別為3.3%和6.8%。在歐洲，預計德國的複合年成長率為4.6%。

全球植物抗體市場－主要趨勢與促進因素摘要

什麼是植物抗體？為什麼生物製藥公司對它們感興趣？

植物抗體是利用分子農業技術在基因工程植物中產生的抗體。它們具有與哺乳動物單株抗體相似的功能，但利用菸草、玉米、水稻和大麥等植物表現系統合成。這些植物來源抗體為傳統生物製藥生產提供了一條替代途徑，特別適用於疫苗、治療和診斷領域。

這個概念具有許多優勢，包括降低生產成本、降低人類病原體污染風險以及可擴展的農業生產。植物抗體正被研究作為感染疾病、癌症和自體免疫疾病治療和診斷套件的組成部分。隨著對快速靈活生產平台的需求不斷成長，尤其是在全球衛生緊急情況下，植物抗體的重要性日益凸顯。

支持植物抗體生產的技術是如何發展？

植物抗體的生產涉及使用農桿菌介導的轉化或病毒載體等技術將抗體編碼基因插入植物細胞。這些基因改造植物隨後在其葉子和種子中產生目標抗體。收穫的材料經過加工和純化，以提取功能性抗體。植物表現載體、糖基化控制和下游純化技術的進步提高了產量及其與人類抗體的生物等效性。

利用植物病毒載體的瞬時表現系統的最新創新，實現了快速生產週期，並使其能夠適應新的疾病目標。植物細胞培養、密閉式培養和分子設計的改進，進一步實現了批次間性能的一致性。糖工程技術正被用於植物來源抗體的人源化，以提高療效並降低免疫抗原性。

該應用程式在哪裡發展以及誰在使用 Plantibody？

一些研究和早期臨床研究正在評估植物抗體對伊波拉出血熱、茲卡、新冠肺炎和某些癌症等疾病的療效。一些生物技術公司和公共衛生機構已經啟動了使用本氏煙和其他模式植物的試驗和中試生產計畫。植物抗體也在獸醫學、食品安全診斷和環境生物感測領域研究。

製藥公司擴大考慮採用基於植物的系統進行大規模、成本敏感的抗體生產。人們對生物相似藥和新型療法的日益關注，推動了對靈活、可擴展且生物安全的生產方式的需求。診斷套件開發商正在利用植物抗體開發快速、穩定且易於運輸的檢測解決方案，尤其是在資源匱乏的環境中。

植物抗體市場的成長受到多種因素的推動。

植物抗體市場的成長動力源自於對經濟高效的生物療法藥物日益成長的需求、植物表現系統基因工程的改進，以及對新興疾病快速抗體生產日益成長的需求。瞬時表達技術的擴展、下游製程的改進以及植物生物安全性的提升，正在推動其應用。

全球衛生診斷領域的應用、對分子農業作為疫情應對措施的興趣，以及生技公司與農業研究人員之間的合作，正在加速其發展。在即時檢測、獸醫治療和被動免疫策略中的應用也增加了市場潛力。隨著法律規範不斷發展以支持植物來源生技藥品，植物抗體有望在製藥研發線和全球衛生策略中得到更廣泛的應用。

部分

基因改造作物（菸草、豆類、穀類、種子/塊莖、水果/蔬菜、其他基因改造作物）、技術（傳統技術、組織培養技術、育種/雜交技術、基因改造種子技術、其他技術）、用途（自體免疫疾病用途、癌症用途、感染疾病用途、疫苗接種用途、牙科用途、其他用途）、最終生物/製藥公司、學術用途（生物/製藥公司、學術用途）

受訪公司範例

• Agrisera AB
• Biolex Therapeutics（Synthon）
• Fraunhofer IME
• Greenovation Biotech GmbH
• IBIO, Inc.
• Icon Genetics（Nomad Bioscience）
• Kentucky BioProcessing Inc.
• Leaf Expression Systems
• Mapp Biopharmaceutical, Inc.
• Medicago Inc.
• Morphosys AG
• Planet Biotechnology Inc.
• PlantForm Corporation
• PlantiBodies（startup）
• Protalix BioTherapeutics Inc.
• Qualcomm of plantibodies **Ventria Bioscience Inc.
• Pfizer Inc.
• ZEA Biosciences
• Biocon Limited
• iVitria/Ventria Affiliates**

人工智慧整合

全球產業分析師利用可操作的專家內容和人工智慧工具改變市場和競爭情報。

Global Industry Analysts 沒有遵循典型的 LLM 或特定於行業的 SLM查詢，而是建立了一個從世界各地的專家收集的內容庫，其中包括影片錄像、BLOG、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地和進出口（成品和原始設備製造商）情況預測其競爭地位的變化。這種複雜而多面的市場動態預計將以多種方式影響競爭對手，包括銷貨成本(COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

• 市場概覽
• 主要企業
• 市場趨勢和促進因素
• 全球市場展望

第3章市場分析

• 美國
• 加拿大
• 日本
• 中國
• 歐洲
• 法國
• 德國
• 義大利
• 英國
• 西班牙
• 俄羅斯
• 其他歐洲國家
• 亞太地區
• 澳洲
• 印度
• 韓國
• 其他亞太地區
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中東
• 伊朗
• 以色列
• 沙烏地阿拉伯
• 阿拉伯聯合大公國
• 其他中東地區
• 非洲

第4章 比賽

Global Plantibodies Market to Reach US$79.5 Million by 2030

The global market for Plantibodies estimated at US$53.2 Million in the year 2024, is expected to reach US$79.5 Million by 2030, growing at a CAGR of 6.9% over the analysis period 2024-2030. Tobacco, one of the segments analyzed in the report, is expected to record a 8.8% CAGR and reach US$24.3 Million by the end of the analysis period. Growth in the Legumes segment is estimated at 4.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$14.5 Million While China is Forecast to Grow at 11.2% CAGR

The Plantibodies market in the U.S. is estimated at US$14.5 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$16.9 Million by the year 2030 trailing a CAGR of 11.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.3% and 6.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.6% CAGR.

Global Plantibodies Market - Key Trends & Drivers Summarized

What Are Plantibodies and Why Are They Attracting Biopharmaceutical Interest?

Plantibodies are antibodies produced in genetically engineered plants through molecular farming. They function similarly to mammalian-derived monoclonal antibodies but are synthesized using plant expression systems such as tobacco, corn, rice, or barley. These plant-based antibodies offer an alternative route to traditional biopharmaceutical manufacturing, particularly for vaccines, therapeutics, and diagnostic agents.

The concept offers several advantages including lower production costs, reduced risk of contamination with human pathogens, and scalable agriculture-based manufacturing. Plantibodies are being explored for the treatment of infectious diseases, cancer, autoimmune conditions, and as components in diagnostic kits. Their relevance grew with increasing demand for rapid and flexible production platforms, especially during global health emergencies.

How Is the Technology Behind Plantibody Production Evolving?

Plantibody production involves inserting antibody-encoding genes into plant cells using techniques like Agrobacterium-mediated transformation or viral vectors. These transgenic plants then produce the desired antibodies in their leaves or seeds. The harvested material is processed and purified to extract functional antibodies. Advances in plant expression vectors, glycosylation control, and downstream purification have improved yield and biological equivalence to human antibodies.

Recent innovations in transient expression systems using plant viral vectors allow rapid production cycles and adaptability to emerging disease targets. Improvements in plant cell culture, containment farming, and molecular design have further enabled consistent performance across batches. Glycoengineering techniques are being used to humanize plant-derived antibodies for improved efficacy and reduced immunogenicity.

Where Are Applications Expanding and Who Is Using Plantibodies?

Research and early-stage clinical studies are evaluating plantibodies for conditions such as Ebola, Zika, COVID-19, and certain cancers. Several biotechnology companies and public health institutions have initiated trials and pilot production programs using Nicotiana benthamiana and other model plants. Plantibodies are also being explored in veterinary medicine, food safety diagnostics, and environmental biosensing.

Pharmaceutical producers are increasingly considering plant-based systems for large-scale, cost-sensitive antibody production. As biosimilars and novel therapeutics become more prominent, the demand for flexible, scalable, and biosafe manufacturing alternatives is growing. Diagnostic kit developers are using plantibodies to create rapid, stable, and transportable testing solutions, particularly for use in low-resource settings.

Growth in the Plantibodies market is driven by several factors…

Growth in the plantibodies market is driven by increasing need for cost-effective biotherapeutics, improved genetic engineering of plant expression systems, and growing demand for rapid antibody production in response to emerging diseases. Expansion of transient expression techniques, improved downstream processing, and the rise of plant-based biosafety profiles are supporting adoption.

Application in global health diagnostics, interest in molecular farming for pandemic preparedness, and partnerships between biotech firms and agriculture researchers are accelerating development. Use in point-of-care testing, veterinary therapeutics, and passive immunization strategies also contributes to market potential. As regulatory frameworks evolve to support plant-based biologics, plantibodies are positioned to gain greater acceptance in pharmaceutical pipelines and global health strategies.

SCOPE OF STUDY:

The report analyzes the Plantibodies market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Transgenic Crop (Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables, Other Transgenic Crops); Technique (Conventional Method Technique, Tissue Culture Technique, Breeding & Sexual Crossing Technique, Transgenic Seeds Technique, Other Techniques); Application (Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application, Other Applications); End-Use (Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 33 Featured) -

• Agrisera AB
• Biolex Therapeutics (Synthon)
• Fraunhofer IME
• Greenovation Biotech GmbH
• IBIO, Inc.
• Icon Genetics (Nomad Bioscience)
• Kentucky BioProcessing Inc.
• Leaf Expression Systems
• Mapp Biopharmaceutical, Inc.
• Medicago Inc.
• Morphosys AG
• Planet Biotechnology Inc.
• PlantForm Corporation
• PlantiBodies (startup)
• Protalix BioTherapeutics Inc.
• Qualcomm of plantibodies?** Ventria Bioscience Inc.
• Pfizer Inc.
• ZEA Biosciences
• Biocon Limited
• iVitria / Ventria Affiliates**

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Plantibodies - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Demand for Cost-Effective Biologics Propels Interest in Plantibody Production Platforms
  • Advancements in Plant Molecular Farming Strengthen the Business Case for Plant-Derived Therapeutic Antibodies
  • Increasing Global Emphasis on Pandemic Preparedness Throws the Spotlight on Rapid-Scale Antibody Manufacturing via Plants
  • Lower Risk of Human Pathogen Contamination Supports Regulatory Momentum for Plant-Based Biopharmaceuticals
  • Growth in Monoclonal Antibody Therapies Expands the Addressable Market for Alternative Expression Systems
  • Technological Innovations in Transient Expression Systems Drive Rapid and Scalable Plantibody Yields
  • Shift Toward Decentralized and Low-Cost Biomanufacturing Fuels Adoption in Emerging and Low-Resource Regions
  • Use of Plantibodies in Veterinary and Agricultural Applications Opens Non-Human Health Market Opportunities
  • Global Expansion of Biosimilar and Biobetter Markets Creates Long-Term Demand for Low-Cost Antibody Production Systems
  • Inclusion of Plantibodies in Orphan Drug and Rare Disease Pipelines Enhances Market Differentiation
  • Challenges in Downstream Processing and Product Consistency Throw the Spotlight on Bioprocess Optimization
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Plantibodies Market Analysis of Annual Sales in US$ for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Plantibodies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Plantibodies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 4: World 16-Year Perspective for Plantibodies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Tobacco by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Tobacco by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 7: World 16-Year Perspective for Tobacco by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Legumes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Legumes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 10: World 16-Year Perspective for Legumes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Cereals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Cereals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 13: World 16-Year Perspective for Cereals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Seeds & Tubers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Seeds & Tubers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 16: World 16-Year Perspective for Seeds & Tubers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Fruits & Vegetables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Fruits & Vegetables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 19: World 16-Year Perspective for Fruits & Vegetables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Other Transgenic Crops by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Other Transgenic Crops by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 22: World 16-Year Perspective for Other Transgenic Crops by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Transgenic Seeds Technique by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Transgenic Seeds Technique by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 25: World 16-Year Perspective for Transgenic Seeds Technique by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Other Techniques by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Other Techniques by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 28: World 16-Year Perspective for Other Techniques by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Conventional Method Technique by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Conventional Method Technique by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 31: World 16-Year Perspective for Conventional Method Technique by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Tissue Culture Technique by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Tissue Culture Technique by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 34: World 16-Year Perspective for Tissue Culture Technique by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Breeding & Sexual Crossing Technique by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Breeding & Sexual Crossing Technique by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 37: World 16-Year Perspective for Breeding & Sexual Crossing Technique by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Autoimmune Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Autoimmune Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 40: World 16-Year Perspective for Autoimmune Diseases Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 41: World Recent Past, Current & Future Analysis for Cancer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 42: World Historic Review for Cancer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 43: World 16-Year Perspective for Cancer Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 44: World Recent Past, Current & Future Analysis for Infectious Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 45: World Historic Review for Infectious Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 46: World 16-Year Perspective for Infectious Diseases Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 47: World Recent Past, Current & Future Analysis for Immunization Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 48: World Historic Review for Immunization Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 49: World 16-Year Perspective for Immunization Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 50: World Recent Past, Current & Future Analysis for Dentistry Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 51: World Historic Review for Dentistry Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 52: World 16-Year Perspective for Dentistry Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 53: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 54: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 55: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 56: World Recent Past, Current & Future Analysis for Biotech & Pharma Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 57: World Historic Review for Biotech & Pharma Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 58: World 16-Year Perspective for Biotech & Pharma Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 59: World Recent Past, Current & Future Analysis for Academic & Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 60: World Historic Review for Academic & Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 61: World 16-Year Perspective for Academic & Research Institutes End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 62: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 63: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 64: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Plantibodies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 65: USA Recent Past, Current & Future Analysis for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 66: USA Historic Review for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 67: USA 16-Year Perspective for Plantibodies by Transgenic Crop - Percentage Breakdown of Value Sales for Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops for the Years 2014, 2025 & 2030
  • TABLE 68: USA Recent Past, Current & Future Analysis for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 69: USA Historic Review for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 70: USA 16-Year Perspective for Plantibodies by Technique - Percentage Breakdown of Value Sales for Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique for the Years 2014, 2025 & 2030
  • TABLE 71: USA Recent Past, Current & Future Analysis for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 72: USA Historic Review for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 73: USA 16-Year Perspective for Plantibodies by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 74: USA Recent Past, Current & Future Analysis for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 75: USA Historic Review for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 76: USA 16-Year Perspective for Plantibodies by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• CANADA
  • TABLE 77: Canada Recent Past, Current & Future Analysis for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Canada Historic Review for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 79: Canada 16-Year Perspective for Plantibodies by Transgenic Crop - Percentage Breakdown of Value Sales for Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops for the Years 2014, 2025 & 2030
  • TABLE 80: Canada Recent Past, Current & Future Analysis for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Canada Historic Review for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 82: Canada 16-Year Perspective for Plantibodies by Technique - Percentage Breakdown of Value Sales for Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique for the Years 2014, 2025 & 2030
  • TABLE 83: Canada Recent Past, Current & Future Analysis for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Canada Historic Review for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 85: Canada 16-Year Perspective for Plantibodies by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 86: Canada Recent Past, Current & Future Analysis for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Canada Historic Review for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 88: Canada 16-Year Perspective for Plantibodies by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• JAPAN
  • Plantibodies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 89: Japan Recent Past, Current & Future Analysis for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Japan Historic Review for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 91: Japan 16-Year Perspective for Plantibodies by Transgenic Crop - Percentage Breakdown of Value Sales for Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops for the Years 2014, 2025 & 2030
  • TABLE 92: Japan Recent Past, Current & Future Analysis for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Japan Historic Review for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 94: Japan 16-Year Perspective for Plantibodies by Technique - Percentage Breakdown of Value Sales for Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique for the Years 2014, 2025 & 2030
  • TABLE 95: Japan Recent Past, Current & Future Analysis for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Japan Historic Review for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 97: Japan 16-Year Perspective for Plantibodies by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 98: Japan Recent Past, Current & Future Analysis for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Japan Historic Review for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 100: Japan 16-Year Perspective for Plantibodies by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• CHINA
  • Plantibodies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 101: China Recent Past, Current & Future Analysis for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 102: China Historic Review for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 103: China 16-Year Perspective for Plantibodies by Transgenic Crop - Percentage Breakdown of Value Sales for Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops for the Years 2014, 2025 & 2030
  • TABLE 104: China Recent Past, Current & Future Analysis for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 105: China Historic Review for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 106: China 16-Year Perspective for Plantibodies by Technique - Percentage Breakdown of Value Sales for Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique for the Years 2014, 2025 & 2030
  • TABLE 107: China Recent Past, Current & Future Analysis for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 108: China Historic Review for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 109: China 16-Year Perspective for Plantibodies by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 110: China Recent Past, Current & Future Analysis for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 111: China Historic Review for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 112: China 16-Year Perspective for Plantibodies by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• EUROPE
  • Plantibodies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 113: Europe Recent Past, Current & Future Analysis for Plantibodies by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 114: Europe Historic Review for Plantibodies by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 115: Europe 16-Year Perspective for Plantibodies by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
  • TABLE 116: Europe Recent Past, Current & Future Analysis for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Europe Historic Review for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 118: Europe 16-Year Perspective for Plantibodies by Transgenic Crop - Percentage Breakdown of Value Sales for Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops for the Years 2014, 2025 & 2030
  • TABLE 119: Europe Recent Past, Current & Future Analysis for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Europe Historic Review for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 121: Europe 16-Year Perspective for Plantibodies by Technique - Percentage Breakdown of Value Sales for Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique for the Years 2014, 2025 & 2030
  • TABLE 122: Europe Recent Past, Current & Future Analysis for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Europe Historic Review for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 124: Europe 16-Year Perspective for Plantibodies by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 125: Europe Recent Past, Current & Future Analysis for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Europe Historic Review for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 127: Europe 16-Year Perspective for Plantibodies by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• FRANCE
  • Plantibodies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 128: France Recent Past, Current & Future Analysis for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 129: France Historic Review for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 130: France 16-Year Perspective for Plantibodies by Transgenic Crop - Percentage Breakdown of Value Sales for Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops for the Years 2014, 2025 & 2030
  • TABLE 131: France Recent Past, Current & Future Analysis for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 132: France Historic Review for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 133: France 16-Year Perspective for Plantibodies by Technique - Percentage Breakdown of Value Sales for Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique for the Years 2014, 2025 & 2030
  • TABLE 134: France Recent Past, Current & Future Analysis for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 135: France Historic Review for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 136: France 16-Year Perspective for Plantibodies by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 137: France Recent Past, Current & Future Analysis for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 138: France Historic Review for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 139: France 16-Year Perspective for Plantibodies by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• GERMANY
  • Plantibodies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 140: Germany Recent Past, Current & Future Analysis for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Germany Historic Review for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 142: Germany 16-Year Perspective for Plantibodies by Transgenic Crop - Percentage Breakdown of Value Sales for Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops for the Years 2014, 2025 & 2030
  • TABLE 143: Germany Recent Past, Current & Future Analysis for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Germany Historic Review for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 145: Germany 16-Year Perspective for Plantibodies by Technique - Percentage Breakdown of Value Sales for Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique for the Years 2014, 2025 & 2030
  • TABLE 146: Germany Recent Past, Current & Future Analysis for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Germany Historic Review for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 148: Germany 16-Year Perspective for Plantibodies by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 149: Germany Recent Past, Current & Future Analysis for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Germany Historic Review for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 151: Germany 16-Year Perspective for Plantibodies by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• ITALY
  • TABLE 152: Italy Recent Past, Current & Future Analysis for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Italy Historic Review for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 154: Italy 16-Year Perspective for Plantibodies by Transgenic Crop - Percentage Breakdown of Value Sales for Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops for the Years 2014, 2025 & 2030
  • TABLE 155: Italy Recent Past, Current & Future Analysis for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Italy Historic Review for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 157: Italy 16-Year Perspective for Plantibodies by Technique - Percentage Breakdown of Value Sales for Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique for the Years 2014, 2025 & 2030
  • TABLE 158: Italy Recent Past, Current & Future Analysis for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Italy Historic Review for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 160: Italy 16-Year Perspective for Plantibodies by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 161: Italy Recent Past, Current & Future Analysis for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Italy Historic Review for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 163: Italy 16-Year Perspective for Plantibodies by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• UNITED KINGDOM
  • Plantibodies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 164: UK Recent Past, Current & Future Analysis for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 165: UK Historic Review for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 166: UK 16-Year Perspective for Plantibodies by Transgenic Crop - Percentage Breakdown of Value Sales for Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops for the Years 2014, 2025 & 2030
  • TABLE 167: UK Recent Past, Current & Future Analysis for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 168: UK Historic Review for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 169: UK 16-Year Perspective for Plantibodies by Technique - Percentage Breakdown of Value Sales for Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique for the Years 2014, 2025 & 2030
  • TABLE 170: UK Recent Past, Current & Future Analysis for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 171: UK Historic Review for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 172: UK 16-Year Perspective for Plantibodies by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 173: UK Recent Past, Current & Future Analysis for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 174: UK Historic Review for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 175: UK 16-Year Perspective for Plantibodies by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• SPAIN
  • TABLE 176: Spain Recent Past, Current & Future Analysis for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Spain Historic Review for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 178: Spain 16-Year Perspective for Plantibodies by Transgenic Crop - Percentage Breakdown of Value Sales for Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops for the Years 2014, 2025 & 2030
  • TABLE 179: Spain Recent Past, Current & Future Analysis for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Spain Historic Review for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 181: Spain 16-Year Perspective for Plantibodies by Technique - Percentage Breakdown of Value Sales for Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique for the Years 2014, 2025 & 2030
  • TABLE 182: Spain Recent Past, Current & Future Analysis for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Spain Historic Review for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 184: Spain 16-Year Perspective for Plantibodies by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 185: Spain Recent Past, Current & Future Analysis for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Spain Historic Review for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 187: Spain 16-Year Perspective for Plantibodies by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• RUSSIA
  • TABLE 188: Russia Recent Past, Current & Future Analysis for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Russia Historic Review for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 190: Russia 16-Year Perspective for Plantibodies by Transgenic Crop - Percentage Breakdown of Value Sales for Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops for the Years 2014, 2025 & 2030
  • TABLE 191: Russia Recent Past, Current & Future Analysis for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Russia Historic Review for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 193: Russia 16-Year Perspective for Plantibodies by Technique - Percentage Breakdown of Value Sales for Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique for the Years 2014, 2025 & 2030
  • TABLE 194: Russia Recent Past, Current & Future Analysis for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Russia Historic Review for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 196: Russia 16-Year Perspective for Plantibodies by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 197: Russia Recent Past, Current & Future Analysis for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Russia Historic Review for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 199: Russia 16-Year Perspective for Plantibodies by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• REST OF EUROPE
  • TABLE 200: Rest of Europe Recent Past, Current & Future Analysis for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Rest of Europe Historic Review for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 202: Rest of Europe 16-Year Perspective for Plantibodies by Transgenic Crop - Percentage Breakdown of Value Sales for Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops for the Years 2014, 2025 & 2030
  • TABLE 203: Rest of Europe Recent Past, Current & Future Analysis for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Rest of Europe Historic Review for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 205: Rest of Europe 16-Year Perspective for Plantibodies by Technique - Percentage Breakdown of Value Sales for Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique for the Years 2014, 2025 & 2030
  • TABLE 206: Rest of Europe Recent Past, Current & Future Analysis for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Rest of Europe Historic Review for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 208: Rest of Europe 16-Year Perspective for Plantibodies by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 209: Rest of Europe Recent Past, Current & Future Analysis for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Rest of Europe Historic Review for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 211: Rest of Europe 16-Year Perspective for Plantibodies by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• ASIA-PACIFIC
  • Plantibodies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 212: Asia-Pacific Recent Past, Current & Future Analysis for Plantibodies by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 213: Asia-Pacific Historic Review for Plantibodies by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 214: Asia-Pacific 16-Year Perspective for Plantibodies by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
  • TABLE 215: Asia-Pacific Recent Past, Current & Future Analysis for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Asia-Pacific Historic Review for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 217: Asia-Pacific 16-Year Perspective for Plantibodies by Transgenic Crop - Percentage Breakdown of Value Sales for Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops for the Years 2014, 2025 & 2030
  • TABLE 218: Asia-Pacific Recent Past, Current & Future Analysis for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Asia-Pacific Historic Review for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 220: Asia-Pacific 16-Year Perspective for Plantibodies by Technique - Percentage Breakdown of Value Sales for Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique for the Years 2014, 2025 & 2030
  • TABLE 221: Asia-Pacific Recent Past, Current & Future Analysis for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Asia-Pacific Historic Review for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 223: Asia-Pacific 16-Year Perspective for Plantibodies by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 224: Asia-Pacific Recent Past, Current & Future Analysis for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Asia-Pacific Historic Review for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 226: Asia-Pacific 16-Year Perspective for Plantibodies by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• AUSTRALIA
  • Plantibodies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 227: Australia Recent Past, Current & Future Analysis for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Australia Historic Review for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 229: Australia 16-Year Perspective for Plantibodies by Transgenic Crop - Percentage Breakdown of Value Sales for Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops for the Years 2014, 2025 & 2030
  • TABLE 230: Australia Recent Past, Current & Future Analysis for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Australia Historic Review for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 232: Australia 16-Year Perspective for Plantibodies by Technique - Percentage Breakdown of Value Sales for Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique for the Years 2014, 2025 & 2030
  • TABLE 233: Australia Recent Past, Current & Future Analysis for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Australia Historic Review for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 235: Australia 16-Year Perspective for Plantibodies by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 236: Australia Recent Past, Current & Future Analysis for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Australia Historic Review for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 238: Australia 16-Year Perspective for Plantibodies by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• INDIA
  • Plantibodies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 239: India Recent Past, Current & Future Analysis for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 240: India Historic Review for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 241: India 16-Year Perspective for Plantibodies by Transgenic Crop - Percentage Breakdown of Value Sales for Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops for the Years 2014, 2025 & 2030
  • TABLE 242: India Recent Past, Current & Future Analysis for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 243: India Historic Review for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 244: India 16-Year Perspective for Plantibodies by Technique - Percentage Breakdown of Value Sales for Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique for the Years 2014, 2025 & 2030
  • TABLE 245: India Recent Past, Current & Future Analysis for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 246: India Historic Review for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 247: India 16-Year Perspective for Plantibodies by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 248: India Recent Past, Current & Future Analysis for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 249: India Historic Review for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 250: India 16-Year Perspective for Plantibodies by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• SOUTH KOREA
  • TABLE 251: South Korea Recent Past, Current & Future Analysis for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 252: South Korea Historic Review for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 253: South Korea 16-Year Perspective for Plantibodies by Transgenic Crop - Percentage Breakdown of Value Sales for Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops for the Years 2014, 2025 & 2030
  • TABLE 254: South Korea Recent Past, Current & Future Analysis for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 255: South Korea Historic Review for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 256: South Korea 16-Year Perspective for Plantibodies by Technique - Percentage Breakdown of Value Sales for Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique for the Years 2014, 2025 & 2030
  • TABLE 257: South Korea Recent Past, Current & Future Analysis for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 258: South Korea Historic Review for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 259: South Korea 16-Year Perspective for Plantibodies by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 260: South Korea Recent Past, Current & Future Analysis for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 261: South Korea Historic Review for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 262: South Korea 16-Year Perspective for Plantibodies by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 263: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Rest of Asia-Pacific Historic Review for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 265: Rest of Asia-Pacific 16-Year Perspective for Plantibodies by Transgenic Crop - Percentage Breakdown of Value Sales for Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops for the Years 2014, 2025 & 2030
  • TABLE 266: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Rest of Asia-Pacific Historic Review for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 268: Rest of Asia-Pacific 16-Year Perspective for Plantibodies by Technique - Percentage Breakdown of Value Sales for Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique for the Years 2014, 2025 & 2030
  • TABLE 269: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Rest of Asia-Pacific Historic Review for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 271: Rest of Asia-Pacific 16-Year Perspective for Plantibodies by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 272: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Rest of Asia-Pacific Historic Review for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 274: Rest of Asia-Pacific 16-Year Perspective for Plantibodies by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• LATIN AMERICA
  • Plantibodies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 275: Latin America Recent Past, Current & Future Analysis for Plantibodies by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 276: Latin America Historic Review for Plantibodies by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 277: Latin America 16-Year Perspective for Plantibodies by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
  • TABLE 278: Latin America Recent Past, Current & Future Analysis for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Latin America Historic Review for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 280: Latin America 16-Year Perspective for Plantibodies by Transgenic Crop - Percentage Breakdown of Value Sales for Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops for the Years 2014, 2025 & 2030
  • TABLE 281: Latin America Recent Past, Current & Future Analysis for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Latin America Historic Review for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 283: Latin America 16-Year Perspective for Plantibodies by Technique - Percentage Breakdown of Value Sales for Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique for the Years 2014, 2025 & 2030
  • TABLE 284: Latin America Recent Past, Current & Future Analysis for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Latin America Historic Review for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 286: Latin America 16-Year Perspective for Plantibodies by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 287: Latin America Recent Past, Current & Future Analysis for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Latin America Historic Review for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 289: Latin America 16-Year Perspective for Plantibodies by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• ARGENTINA
  • TABLE 290: Argentina Recent Past, Current & Future Analysis for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Argentina Historic Review for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 292: Argentina 16-Year Perspective for Plantibodies by Transgenic Crop - Percentage Breakdown of Value Sales for Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops for the Years 2014, 2025 & 2030
  • TABLE 293: Argentina Recent Past, Current & Future Analysis for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Argentina Historic Review for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 295: Argentina 16-Year Perspective for Plantibodies by Technique - Percentage Breakdown of Value Sales for Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique for the Years 2014, 2025 & 2030
  • TABLE 296: Argentina Recent Past, Current & Future Analysis for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Argentina Historic Review for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 298: Argentina 16-Year Perspective for Plantibodies by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 299: Argentina Recent Past, Current & Future Analysis for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Argentina Historic Review for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 301: Argentina 16-Year Perspective for Plantibodies by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• BRAZIL
  • TABLE 302: Brazil Recent Past, Current & Future Analysis for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Brazil Historic Review for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 304: Brazil 16-Year Perspective for Plantibodies by Transgenic Crop - Percentage Breakdown of Value Sales for Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops for the Years 2014, 2025 & 2030
  • TABLE 305: Brazil Recent Past, Current & Future Analysis for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Brazil Historic Review for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 307: Brazil 16-Year Perspective for Plantibodies by Technique - Percentage Breakdown of Value Sales for Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique for the Years 2014, 2025 & 2030
  • TABLE 308: Brazil Recent Past, Current & Future Analysis for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Brazil Historic Review for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 310: Brazil 16-Year Perspective for Plantibodies by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 311: Brazil Recent Past, Current & Future Analysis for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Brazil Historic Review for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 313: Brazil 16-Year Perspective for Plantibodies by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• MEXICO
  • TABLE 314: Mexico Recent Past, Current & Future Analysis for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 315: Mexico Historic Review for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 316: Mexico 16-Year Perspective for Plantibodies by Transgenic Crop - Percentage Breakdown of Value Sales for Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops for the Years 2014, 2025 & 2030
  • TABLE 317: Mexico Recent Past, Current & Future Analysis for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 318: Mexico Historic Review for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 319: Mexico 16-Year Perspective for Plantibodies by Technique - Percentage Breakdown of Value Sales for Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique for the Years 2014, 2025 & 2030
  • TABLE 320: Mexico Recent Past, Current & Future Analysis for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 321: Mexico Historic Review for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 322: Mexico 16-Year Perspective for Plantibodies by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 323: Mexico Recent Past, Current & Future Analysis for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 324: Mexico Historic Review for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 325: Mexico 16-Year Perspective for Plantibodies by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 326: Rest of Latin America Recent Past, Current & Future Analysis for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 327: Rest of Latin America Historic Review for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 328: Rest of Latin America 16-Year Perspective for Plantibodies by Transgenic Crop - Percentage Breakdown of Value Sales for Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops for the Years 2014, 2025 & 2030
  • TABLE 329: Rest of Latin America Recent Past, Current & Future Analysis for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 330: Rest of Latin America Historic Review for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 331: Rest of Latin America 16-Year Perspective for Plantibodies by Technique - Percentage Breakdown of Value Sales for Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique for the Years 2014, 2025 & 2030
  • TABLE 332: Rest of Latin America Recent Past, Current & Future Analysis for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 333: Rest of Latin America Historic Review for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 334: Rest of Latin America 16-Year Perspective for Plantibodies by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 335: Rest of Latin America Recent Past, Current & Future Analysis for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 336: Rest of Latin America Historic Review for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 337: Rest of Latin America 16-Year Perspective for Plantibodies by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• MIDDLE EAST
  • Plantibodies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 338: Middle East Recent Past, Current & Future Analysis for Plantibodies by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 339: Middle East Historic Review for Plantibodies by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 340: Middle East 16-Year Perspective for Plantibodies by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
  • TABLE 341: Middle East Recent Past, Current & Future Analysis for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 342: Middle East Historic Review for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 343: Middle East 16-Year Perspective for Plantibodies by Transgenic Crop - Percentage Breakdown of Value Sales for Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops for the Years 2014, 2025 & 2030
  • TABLE 344: Middle East Recent Past, Current & Future Analysis for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 345: Middle East Historic Review for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 346: Middle East 16-Year Perspective for Plantibodies by Technique - Percentage Breakdown of Value Sales for Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique for the Years 2014, 2025 & 2030
  • TABLE 347: Middle East Recent Past, Current & Future Analysis for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 348: Middle East Historic Review for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 349: Middle East 16-Year Perspective for Plantibodies by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 350: Middle East Recent Past, Current & Future Analysis for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 351: Middle East Historic Review for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 352: Middle East 16-Year Perspective for Plantibodies by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• IRAN
  • TABLE 353: Iran Recent Past, Current & Future Analysis for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 354: Iran Historic Review for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 355: Iran 16-Year Perspective for Plantibodies by Transgenic Crop - Percentage Breakdown of Value Sales for Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops for the Years 2014, 2025 & 2030
  • TABLE 356: Iran Recent Past, Current & Future Analysis for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 357: Iran Historic Review for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 358: Iran 16-Year Perspective for Plantibodies by Technique - Percentage Breakdown of Value Sales for Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique for the Years 2014, 2025 & 2030
  • TABLE 359: Iran Recent Past, Current & Future Analysis for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 360: Iran Historic Review for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 361: Iran 16-Year Perspective for Plantibodies by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 362: Iran Recent Past, Current & Future Analysis for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 363: Iran Historic Review for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 364: Iran 16-Year Perspective for Plantibodies by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• ISRAEL
  • TABLE 365: Israel Recent Past, Current & Future Analysis for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 366: Israel Historic Review for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 367: Israel 16-Year Perspective for Plantibodies by Transgenic Crop - Percentage Breakdown of Value Sales for Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops for the Years 2014, 2025 & 2030
  • TABLE 368: Israel Recent Past, Current & Future Analysis for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 369: Israel Historic Review for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 370: Israel 16-Year Perspective for Plantibodies by Technique - Percentage Breakdown of Value Sales for Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique for the Years 2014, 2025 & 2030
  • TABLE 371: Israel Recent Past, Current & Future Analysis for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 372: Israel Historic Review for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 373: Israel 16-Year Perspective for Plantibodies by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 374: Israel Recent Past, Current & Future Analysis for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 375: Israel Historic Review for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 376: Israel 16-Year Perspective for Plantibodies by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• SAUDI ARABIA
  • TABLE 377: Saudi Arabia Recent Past, Current & Future Analysis for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 378: Saudi Arabia Historic Review for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 379: Saudi Arabia 16-Year Perspective for Plantibodies by Transgenic Crop - Percentage Breakdown of Value Sales for Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops for the Years 2014, 2025 & 2030
  • TABLE 380: Saudi Arabia Recent Past, Current & Future Analysis for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 381: Saudi Arabia Historic Review for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 382: Saudi Arabia 16-Year Perspective for Plantibodies by Technique - Percentage Breakdown of Value Sales for Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique for the Years 2014, 2025 & 2030
  • TABLE 383: Saudi Arabia Recent Past, Current & Future Analysis for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 384: Saudi Arabia Historic Review for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 385: Saudi Arabia 16-Year Perspective for Plantibodies by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 386: Saudi Arabia Recent Past, Current & Future Analysis for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 387: Saudi Arabia Historic Review for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 388: Saudi Arabia 16-Year Perspective for Plantibodies by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 389: UAE Recent Past, Current & Future Analysis for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 390: UAE Historic Review for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 391: UAE 16-Year Perspective for Plantibodies by Transgenic Crop - Percentage Breakdown of Value Sales for Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops for the Years 2014, 2025 & 2030
  • TABLE 392: UAE Recent Past, Current & Future Analysis for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 393: UAE Historic Review for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 394: UAE 16-Year Perspective for Plantibodies by Technique - Percentage Breakdown of Value Sales for Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique for the Years 2014, 2025 & 2030
  • TABLE 395: UAE Recent Past, Current & Future Analysis for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 396: UAE Historic Review for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 397: UAE 16-Year Perspective for Plantibodies by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 398: UAE Recent Past, Current & Future Analysis for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 399: UAE Historic Review for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 400: UAE 16-Year Perspective for Plantibodies by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 401: Rest of Middle East Recent Past, Current & Future Analysis for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 402: Rest of Middle East Historic Review for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 403: Rest of Middle East 16-Year Perspective for Plantibodies by Transgenic Crop - Percentage Breakdown of Value Sales for Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops for the Years 2014, 2025 & 2030
  • TABLE 404: Rest of Middle East Recent Past, Current & Future Analysis for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 405: Rest of Middle East Historic Review for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 406: Rest of Middle East 16-Year Perspective for Plantibodies by Technique - Percentage Breakdown of Value Sales for Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique for the Years 2014, 2025 & 2030
  • TABLE 407: Rest of Middle East Recent Past, Current & Future Analysis for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 408: Rest of Middle East Historic Review for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 409: Rest of Middle East 16-Year Perspective for Plantibodies by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 410: Rest of Middle East Recent Past, Current & Future Analysis for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 411: Rest of Middle East Historic Review for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 412: Rest of Middle East 16-Year Perspective for Plantibodies by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• AFRICA
  • Plantibodies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 413: Africa Recent Past, Current & Future Analysis for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 414: Africa Historic Review for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 415: Africa 16-Year Perspective for Plantibodies by Transgenic Crop - Percentage Breakdown of Value Sales for Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops for the Years 2014, 2025 & 2030
  • TABLE 416: Africa Recent Past, Current & Future Analysis for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 417: Africa Historic Review for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 418: Africa 16-Year Perspective for Plantibodies by Technique - Percentage Breakdown of Value Sales for Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique for the Years 2014, 2025 & 2030
  • TABLE 419: Africa Recent Past, Current & Future Analysis for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 420: Africa Historic Review for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 421: Africa 16-Year Perspective for Plantibodies by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 422: Africa Recent Past, Current & Future Analysis for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 423: Africa Historic Review for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 424: Africa 16-Year Perspective for Plantibodies by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses for the Years 2014, 2025 & 2030

IV. COMPETITION